Parkinson's disease, dopamine pathways, movement disorders, and neuroprotection
124 articles
A comprehensive review examines how marine-derived bioactives like omega-3s, astaxanthin, and polysaccharides may combat chronic neuroinflammation underlying major neurodegenerative diseases.
Explorez ce qui se passe réellement dans votre cerveau à mesure que vous vieillissez — des réseaux de neurones qui se réduisent aux modifications des substances chimiques cérébrales — et découvrez pourquoi certaines personnes restent mentalement vives bien au-delà de 80 ans.
New review maps how α-synuclein assays may detect Parkinson's before symptoms appear — and what stands between lab and clinic.
A new Cell Metabolism study reveals how oxidative stress triggers astrocytes to produce collagen, forming barriers that kill neurons after stroke.
A landmark review argues neurodegeneration is driven by interacting misfolded proteins, not single culprits — reshaping diagnosis and treatment.
A new AI classifier using just 15 proteins achieves 95.5% AUC accuracy across Alzheimer's, Parkinson's, FTD, and Lewy body dementia.
NYU professor Scott Galloway and Andrew Huberman unpack what it takes for men to build meaning, health, and economic stability today.
Neuroscientist Dr. Tommy Wood breaks down diet, exercise, supplementation, and cognitive stimulation strategies to protect brain health across your lifespan.
New research links early dopamine neuron dysfunction in the entorhinal cortex to memory loss in Alzheimer's — and L-DOPA reversed it in mice.
First 6-month RCT shows PAP therapy meaningfully improves MoCA scores and motor function in Parkinson's patients with OSA.
New review reveals how protein clumps and cellular powerhouses work together to drive neurodegeneration in Parkinson's disease.
Large international study reveals how current antidepressant use affects brain structure in people with major depression.
